CPT code 58674 represents laparoscopic radiofrequency ablation of uterine fibroids performed under ultrasound guidance. This minimally invasive gynecologic procedure targets benign fibrous tumors of the uterus to reduce symptoms such as heavy bleeding, pelvic pain, and bulk-related discomfort. Nationally, the code matters because it reflects adoption of image-guided, uterus-sparing treatments that can shorten recovery compared with open surgery and influence surgical choice and coverage policies.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, common settings of care, and the types of benchmarks and policy topics typically associated with this code, including utilization patterns, site-of-service considerations, and prior authorization or coverage trends. The publication outlines where this service sits in the care pathway for symptomatic fibroids and what stakeholders commonly monitor: frequency of use, place-of-service shifts (ambulatory surgery center versus hospital), and payer coverage criteria.

Information presented is intended to provide clinical and billing clarity for stakeholders reviewing CPT code 58674, including coding teams, clinicians, and policy analysts. Data not available in the input.